Literature DB >> 23242016

[Natural history and overlap of functional gastrointestinal disorders].

Rok Seon Choung1.   

Abstract

Functional gastrointestinal (GI) disorders are common in the general population. Based on the Rome III classification, these disorders are mutually exclusive disorders keeping the homogeneity of each functional GI disorder in research area. In contrast, many population and clinical studies have reported a considerably high rate of overlap between functional GI disorders. The overlap of functional GI disorders over other intestinal diseases might simply occur by chance due to a highly prevalent disorder. Moreover, functional GI disorders is considered a chronic stable disorder that may wax and wane for several years. However, a recent study about the natural history of functional GI disorders showed substantial transition among functional GI disorders over time. The natural history of functional GI disorders with overlapping other functional GI disorders are still in infancy and better understanding of these will be important in determining the efficacy of future therapeutic interventions.

Entities:  

Mesh:

Year:  2012        PMID: 23242016     DOI: 10.4166/kjg.2012.60.6.345

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  2 in total

1.  Functional Gastrointestinal Disorders in Young Military Men.

Authors:  Chang Seok Bang; Yeon Soo Kim; Jin Hyung Han; Yong Sub Lee; Gwang Ho Baik; Jin Bong Kim; Ki Tae Suk; Jai Hoon Yoon; Dong Joon Kim
Journal:  Gut Liver       Date:  2015-07       Impact factor: 4.519

2.  Nationwide Multicenter Study for Overlaps of Common Functional Gastrointestinal Disorders in Korean Patients With Constipation.

Authors:  Kyung Sik Park; Sam Ryong Jee; Bong Eun Lee; Kyoung Sup Hong; Jeong Eun Shin; Soo-Young Na; Joong Goo Kwon; Suck Chei Choi; Yong Sung Kim; Hyun Seok Lee; Tae Hee Lee; Kyeong Ok Kim; Jongkyoung Choi; Hee Seok Moon; Yeon Soo Kim; Moo In Park; Soo Jung Park; Seon-Young Park; Sung Noh Hong
Journal:  J Neurogastroenterol Motil       Date:  2017-10-30       Impact factor: 4.924

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.